Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis - Concepedia

Concepedia

Publication | Open Access

Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis

DOI Full Paper Access

17

Citations

16

References

2019

Year

Judy Nee, Jeffrey M. Johnston, Elizabeth P. Shea, Courtney Walls, Kenneth Tripp, Steven J. Shiff, Susan M. Fox, Wieslaw Bochenek, Darren Weissman, Mark G. Currie,

Expert Review of Gastroenterology & Hepatology

Abstract

These pooled analyses of patients treated for ≤104 weeks confirm linaclotide's overall safety.

References

	Year	Citations

Page 1